This is what I've been looking for!!!
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants, study finds
Researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
Date:July 1, 2021Source:La Jolla Institute for ImmunologySummary:Researchers have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants.
.....The group is now studying a much larger group of 12 different Variants of Concern (VOCs) and Variants of Interest (VOIs), including the Delta variant (B.1.617.2), Eta (B.1.525), Iota (B.1.526), Kappa (B.1.617.1), Lambda (C37) and the variants B.1.526.1, B.1.617.3, R1 and B.1.1.519.
Researchers have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants.
www.sciencedaily.com
Then why do you need antibodies if the T-Cells have the template???
Anyone got any peer reviews???
Greg